Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-12-09

Clinical Trial Update: Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cryotherapy followed by tirbanibulin ointment for actinic keratosis on the scalp and forehead; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirbanibulin ointment (tirbanibulin)

Snippet

Sponsor: University Hospital, Lille | Conditions: Keratosis, Actinic Keratoses | Phase 3 | Status: NOT_YET_RECRUITING